Status:
UNKNOWN
Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population.
Lead Sponsor:
Clinica Universidad de Navarra, Universidad de Navarra
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
75+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether an omega-3 fatty acid supplementation is effective in the prevention of progressive cognitive decline in elderly people aged 75 years or older.
Detailed Description
Participants are residents at three nursing homes in Pamplona (Spain). We assumed that 20% of elderly people have a cognitive decline and we estimated a 5% of cognitive decline in the intervention gro...
Eligibility Criteria
Inclusion
- Elderly people aged 75 years or older
- Global Deterioration Scale \< 4
- Capacity to complete the tests
Exclusion
- Neurological, physical or psychiatry conditions, obtained from the medical history, that may have an influence on the cognitive function.
- Dementia
- History of epilepsy, convulsions
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT01817101
Start Date
January 1 2012
End Date
December 1 2015
Last Update
July 17 2015
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Amma Argaray
Pamplona, Navarre, Spain
2
AMMA Mutilva
Pamplona, Navarre, Spain
3
AMMA Oblatas
Pamplona, Navarre, Spain